Hypoglycemia
Definition
Hypoglycemia is a clinical syndrome caused by low plasma glucose, resulting in autonomic and/or neuroglycopenic symptoms.
Biochemical Cut-offs (Adults)
|
Plasma glucose |
Clinical relevance |
|
<70 mg/dL (3.9 mmol/L) |
Alert value – initiate evaluation |
|
<54 mg/dL (3.0 mmol/L) |
Clinically significant hypoglycemia |
|
Severe hypoglycemia |
Any glucose causing altered sensorium / seizures / coma or requiring assistance |
(ADA / Endocrine Society aligned)
Whipple’s Triad (Diagnostic Cornerstone)
- Symptoms of hypoglycemia
- Documented low plasma glucose
- Relief of symptoms after glucose correction
Pathophysiology
- Brain depends almost exclusively on glucose
- Counter-regulatory hormones:
- Glucagon (first line)
- Epinephrine
- Cortisol
- Growth hormone
- Failure occurs due to:
- Excess insulin (endogenous/exogenous)
- Reduced gluconeogenesis (liver failure, alcohol)
- Increased glucose utilization (sepsis)
- Impaired hormonal response (long-standing diabetes, autonomic neuropathy)
Clinical Features
Autonomic (Adrenergic / Cholinergic)
- Palpitations, tremor
- Anxiety
- Sweating
- Hunger
Neuroglycopenic
- Confusion, behavioral change
- Slurred speech
- Seizures
- Coma
Exam Pearl: Elderly & long-standing diabetics may have hypoglycemia unawareness (blunted adrenergic response).
Etiology – Systematic Approach
1. Drug-Induced (Most Common)
- Insulin (overdose, missed meals)
- Sulfonylureas / meglitinides
- Quinolones, pentamidine, beta-blockers (mask symptoms)
2. Critical Illness–Related
- Sepsis
- Acute liver failure
- Renal failure
- Malnutrition
3. Endogenous Hyperinsulinism
- Insulinoma
- Post-bariatric hypoglycemia
- Autoimmune insulin syndrome
4. Hormonal Deficiency
- Adrenal insufficiency
- Hypopituitarism
5. Alcohol-Related
- Inhibits gluconeogenesis
- Typically fasting hypoglycemia
Diagnostic Evaluation (During Hypoglycemia)
|
Test |
Interpretation |
|
Plasma glucose |
Confirm hypoglycemia |
|
Insulin |
Inappropriately high → hyperinsulinism |
|
C-peptide |
↑ endogenous insulin |
|
Proinsulin |
↑ insulinoma |
|
Sulfonylurea screen |
Drug-induced |
|
Beta-hydroxybutyrate |
Suppressed in hyperinsulinism |
|
Cortisol |
Rule out adrenal insufficiency |
Blood samples must be drawn at the time of hypoglycemia because
When plasma glucose falls:
- Insulin should be fully suppressed
- Counter-regulatory hormones rise
If blood is drawn after glucose correction:
- Insulin levels fall (even if pathologic earlier)
- C-peptide normalizes
- Ketogenesis restarts
- Diagnostic patterns disappear
➡️ You lose the pathological biochemical fingerprint
1️⃣ Normal Physiologic Response to Hypoglycemia
(NO excess insulin)
When glucose falls:
- Insulin ↓↓↓ (appropriately suppressed)
- Lipolysis ↑
- Ketogenesis ↑
➡️ β-hydroxybutyrate = HIGH
Seen in:
- Fasting hypoglycemia
- Malnutrition
- Adrenal insufficiency
- Liver disease
This is the expected / normal response
2️⃣ Hyperinsulinemic Hypoglycemia
(Insulin present when it shouldn’t be)
Insulin blocks lipolysis & ketogenesis, even during hypoglycemia.
➡️ β-hydroxybutyrate = SUPPRESSED (LOW)
Seen in:
- Insulinoma
- Sulfonylurea-induced hypoglycemia
- Exogenous insulin overdose
This is pathologic
What the “Critical Sample” Demonstrates
Blood drawn during hypoglycemia allows you to determine whether insulin is appropriately suppressed or inappropriately elevated.
Expected Physiology During Hypoglycemia
|
Parameter |
Normal response |
|
Insulin |
Very low / undetectable |
|
C-peptide |
Low |
|
Proinsulin |
Low |
|
Beta-hydroxybutyrate |
High (ketosis) |
|
Free fatty acids |
High |
What Goes Wrong in Pathological States
Only a sample drawn at the time of hypoglycemia can reveal this:
|
Condition |
Insulin |
C-peptide |
Ketones |
|
Insulinoma |
Inappropriately high |
High |
Suppressed |
|
Sulfonylurea |
High |
High |
Suppressed |
|
Exogenous insulin |
High |
Low |
Suppressed |
|
Alcohol hypoglycemia |
Low |
Low |
Low ketones |
|
Adrenal insufficiency |
Low |
Low |
Variable |
➡️ After glucose correction, all these patterns may normalize
Management
Immediate Treatment
Conscious Patient
- 15–20 g oral glucose
- Recheck in 15 min (“15-15 rule”)
Unconscious / NPO
- IV dextrose
- Adults: 25 g (50 mL of 50% dextrose)
- If no IV access:
- Glucagon IM/SC
Special Situations
Sulfonylurea-Induced Hypoglycemia
- Octreotide (prevents recurrent hypoglycemia)
- Continuous glucose monitoring
Alcohol-Related
- Thiamine before glucose (prevent Wernicke’s)
ICU & Inpatient Considerations
- Avoid over-tight glycemic control
- Target glucose: 140–180 mg/dL (critically ill)
- Frequent monitoring in:
- Sepsis
- Renal failure
- Insulin infusions
Complications
- Seizures
- Arrhythmias
- Permanent neurological injury
- Death (especially nocturnal hypoglycemia)
Key Exam Pearls
- Neuroglycopenic symptoms = dangerous
- Sulfonylurea hypoglycemia → recurrent
- Insulinoma: fasting hypoglycemia + high insulin + high C-peptide
- Alcohol causes hypoglycemia by blocking gluconeogenesis
- Beta-blockers mask adrenergic symptoms

